ANATOMICAL THERAPEUTIC CHEMICAL (ATC) CLASSIFICATION SYSTEM |
|||||||||||||||
[WHO Collaborating Centre for Drug Statistics Methodology (WHOCC)] |
|||||||||||||||
|
|||||||||||||||
|
G |
|
|||||||||||||
|
G | GENITO URINARY SYSTEM AND SEX HORMONES | Show WHO |
G01 | GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS | Show WHO |
G01A | ANTIINFECTIVES AND ANTISEPTICS, EXCLUDING COMBINATIONS | Show WHO |
G01AA | Antibiotics | Show WHO |
G01AA01 | Nystatin | Show WHO |
G01AA02 | Natamycin | Show WHO |
G01AA03 | Amphotericin B | Show WHO |
G01AA04 | Candicidin | Show WHO |
G01AA05 | Chloramphenicol | Show WHO |
G01AA06 | Hachimycin | Show WHO |
G01AA07 | Oxytetracycline | Show WHO |
G01AA08 | Carfecillin | Show WHO |
G01AA09 | Mepartricin | Show WHO |
G01AA10 | Clindamycin | Show WHO |
G01AA11 | Pentamycin | Show WHO |
G01AA51 | Nystatin, combinations | Show WHO |
G01AB | Arsenic compounds | Show WHO |
G01AB01 | Acetarsol | Show WHO |
G01AC | Quinoline derivatives | Show WHO |
G01AC01 | Diiodohydroxyquinoline | Show WHO |
G01AC02 | Clioquinol | Show WHO |
G01AC03 | Chlorquinaldol | Show WHO |
G01AC05 | Dequalinium | Show WHO |
G01AC06 | Broxyquinoline | Show WHO |
G01AC30 | Oxyquinoline | Show WHO |
G01AD | Organic acids | Show WHO |
G01AD01 | Lactic acid | Show WHO |
G01AD02 | Acetic acid | Show WHO |
G01AD03 | Ascorbic acid | Show WHO |
G01AE | Sulfonamides | Show WHO |
G01AE01 | Sulfatolamide | Show WHO |
G01AE10 | Combinations of sulfonamides | Show WHO |
G01AF | Imidazole derivatives | Show WHO |
G01AF01 | Metronidazole | Show WHO |
G01AF02 | Clotrimazole | Show WHO |
G01AF04 | Miconazole | Show WHO |
G01AF05 | Econazole | Show WHO |
G01AF06 | Ornidazole | Show WHO |
G01AF07 | Isoconazole | Show WHO |
G01AF08 | Tioconazole | Show WHO |
G01AF11 | Ketoconazole | Show WHO |
G01AF12 | Fenticonazole | Show WHO |
G01AF13 | Azanidazole | Show WHO |
G01AF14 | Propenidazole | Show WHO |
G01AF15 | Butoconazole | Show WHO |
G01AF16 | Omoconazole | Show WHO |
G01AF17 | Oxiconazole | Show WHO |
G01AF20 | Combinations of imidazole derivatives | Show WHO |
G01AG | Triazole derivatives | Show WHO |
G01AG02 | Terconazole | Show WHO |
G01AX | Other antiinfectives and antiseptics | Show WHO |
G01AX01 | Clodantoin | Show WHO |
G01AX02 | Inosine | Show WHO |
G01AX03 | Policresulen | Show WHO |
G01AX05 | Nifuratel | Show WHO |
G01AX06 | Furazolidone | Show WHO |
G01AX09 | Methylrosaniline | Show WHO |
G01AX11 | Povidone-iodine | Show WHO |
G01AX12 | Ciclopirox | Show WHO |
G01AX13 | Protiofate | Show WHO |
G01AX14 | Lactobacillus fermentum | Show WHO |
G01AX15 | Copper usnate | Show WHO |
G01AX66 | Octenidine, combinations | Show WHO |
G01B | ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS | Show WHO |
G01BA | Antibiotics and corticosteroids | Show WHO |
G01BC | Quinoline derivatives and corticosteroids | Show WHO |
G01BD | Antiseptics and corticosteroids | Show WHO |
G01BE | Sulfonamides and corticosteroids | Show WHO |
G01BF | Imidazole derivatives and corticosteroids | Show WHO |
G02 | OTHER GYNECOLOGICALS | Show WHO |
G02A | OXYTOCICS | Show WHO |
G02AB | Ergot alkaloids | Show WHO |
G02AB01 | Methylergometrine | Show WHO |
G02AB02 | Ergot alkaloids | Show WHO |
G02AB03 | Ergometrine | Show WHO |
G02AC | Ergot alkaloids and oxytocin incl. analogues, in combination | Show WHO |
G02AC01 | Methylergometrine and oxytocin | Show WHO |
G02AD | Prostaglandins | Show WHO |
G02AD01 | Dinoprost | Show WHO |
G02AD02 | Dinoprostone | Show WHO |
G02AD03 | Gemeprost | Show WHO |
G02AD04 | Carboprost | Show WHO |
G02AD05 | Sulprostone | Show WHO |
G02AX | Other oxytocics | Show WHO |
G02B | CONTRACEPTIVES FOR TOPICAL USE | Show WHO |
G02BA | Intrauterine contraceptives | Show WHO |
G02BA01 | Plastic IUD | Show WHO |
G02BA02 | Plastic IUD with copper | Show WHO |
G02BA03 | Plastic IUD with progestogen | Show WHO |
G02BB | Intravaginal contraceptives | Show WHO |
G02BB01 | Vaginal ring with progestogen and estrogen | Show WHO |
G02C | OTHER GYNECOLOGICALS | Show WHO |
G02CA | Sympathomimetics, labour repressants | Show WHO |
G02CA01 | Ritodrine | Show WHO |
G02CA02 | Buphenine | Show WHO |
G02CA03 | Fenoterol | Show WHO |
G02CB | Prolactine inhibitors | Show WHO |
G02CB01 | Bromocriptine | Show WHO |
G02CB02 | Lisuride | Show WHO |
G02CB03 | Cabergoline | Show WHO |
G02CB04 | Quinagolide | Show WHO |
G02CB05 | Metergoline | Show WHO |
G02CC | Antiinflammatory products for vaginal administration | Show WHO |
G02CC01 | Ibuprofen | Show WHO |
G02CC02 | Naproxen | Show WHO |
G02CC03 | Benzydamine | Show WHO |
G02CC04 | Flunoxaprofen | Show WHO |
G02CX | Other gynecologicals | Show WHO |
G02CX01 | Atosiban | Show WHO |
G03 | SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | Show WHO |
G03A | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE | Show WHO |
G03AA | Progestogens and estrogens, fixed combinations | Show WHO |
G03AA01 | Etynodiol and estrogen | Show WHO |
G03AA02 | Quingestanol and estrogen | Show WHO |
G03AA03 | Lynestrenol and estrogen | Show WHO |
G03AA04 | Megestrol and estrogen | Show WHO |
G03AA05 | Norethisterone and estrogen | Show WHO |
G03AA06 | Norgestrel and estrogen | Show WHO |
G03AA07 | Levonorgestrel and estrogen | Show WHO |
G03AA08 | Medroxyprogesterone and estrogen | Show WHO |
G03AA09 | Desogestrel and estrogen | Show WHO |
G03AA10 | Gestodene and estrogen | Show WHO |
G03AA11 | Norgestimate and estrogen | Show WHO |
G03AA12 | Drospirenone and estrogen | Show WHO |
G03AA13 | Norelgestromin and estrogen | Show WHO |
G03AB | Progestogens and estrogens, sequential preparations | Show WHO |
G03AB01 | Megestrol and estrogen | Show WHO |
G03AB02 | Lynestrenol and estrogen | Show WHO |
G03AB03 | Levonorgestrel and estrogen | Show WHO |
G03AB04 | Norethisterone and estrogen | Show WHO |
G03AB05 | Desogestrel and estrogen | Show WHO |
G03AB06 | Gestodene and estrogen | Show WHO |
G03AB07 | Chlormadinone and estrogen | Show WHO |
G03AC | Progestogens | Show WHO |
G03AC01 | Norethisterone | Show WHO |
G03AC02 | Lynestrenol | Show WHO |
G03AC03 | Levonorgestrel | Show WHO |
G03AC04 | Quingestanol | Show WHO |
G03AC05 | Megestrol | Show WHO |
G03AC06 | Medroxyprogesterone | Show WHO |
G03AC07 | Norgestrienone | Show WHO |
G03AC08 | Etonogestrel | Show WHO |
G03AC09 | Desogestrel | Show WHO |
G03B | ANDROGENS | Show WHO |
G03BA | 3-oxoandrosten (4) derivatives | Show WHO |
G03BA01 | Fluoxymesterone | Show WHO |
G03BA02 | Methyltestosterone | Show WHO |
G03BA03 | Testosterone | Show WHO |
G03BB | 5-androstanon (3) derivatives | Show WHO |
G03BB01 | Mesterolone | Show WHO |
G03BB02 | Androstanolone | Show WHO |
G03C | ESTROGENS | Show WHO |
G03CA | Natural and semisynthetic estrogens, plain | Show WHO |
G03CA01 | Ethinylestradiol | Show WHO |
G03CA03 | Estradiol | Show WHO |
G03CA04 | Estriol | Show WHO |
G03CA06 | Chlorotrianisene | Show WHO |
G03CA07 | Estrone | Show WHO |
G03CA09 | Promestriene | Show WHO |
G03CA53 | Estradiol, combinations | Show WHO |
G03CA57 | Conjugated estrogens | Show WHO |
G03CB | Synthetic estrogens, plain | Show WHO |
G03CB01 | Dienestrol | Show WHO |
G03CB02 | Diethylstilbestrol | Show WHO |
G03CB03 | Methallenestril | Show WHO |
G03CB04 | Moxestrol | Show WHO |
G03CC | Estrogens, combinations with other drugs | Show WHO |
G03CC02 | Dienestrol | Show WHO |
G03CC03 | Methallenestril | Show WHO |
G03CC04 | Estrone | Show WHO |
G03CC05 | Diethylstilbestrol | Show WHO |
G03CC06 | Estriol | Show WHO |
G03D | PROGESTOGENS | Show WHO |
G03DA | Pregnen (4) derivatives | Show WHO |
G03DA01 | Gestonorone | Show WHO |
G03DA02 | Medroxyprogesterone | Show WHO |
G03DA03 | Hydroxyprogesterone | Show WHO |
G03DA04 | Progesterone | Show WHO |
G03DB | Pregnadien derivatives | Show WHO |
G03DB01 | Dydrogesterone | Show WHO |
G03DB02 | Megestrol | Show WHO |
G03DB03 | Medrogestone | Show WHO |
G03DB04 | Nomegestrol | Show WHO |
G03DB05 | Demegestone | Show WHO |
G03DB06 | Chlormadinone | Show WHO |
G03DB07 | Promegestone | Show WHO |
G03DC | Estren derivatives | Show WHO |
G03DC01 | Allylestrenol | Show WHO |
G03DC02 | Norethisterone | Show WHO |
G03DC03 | Lynestrenol | Show WHO |
G03DC04 | Ethisterone | Show WHO |
G03DC05 | Tibolone | Show WHO |
G03DC06 | Etynodiol | Show WHO |
G03DC31 | Methylestrenolone | Show WHO |
G03E | ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION | Show WHO |
G03EA | Androgens and estrogens | Show WHO |
G03EA01 | Methyltestosterone and estrogen | Show WHO |
G03EA02 | Testosterone and estrogen | Show WHO |
G03EA03 | Prasterone and estrogen | Show WHO |
G03EB | Androgen, progestogen and estrogen in combination | Show WHO |
G03EK | Androgens and female sex hormones in combination with other drugs | Show WHO |
G03EK01 | Methyltestosterone | Show WHO |
G03F | PROGESTOGENS AND ESTROGENS IN COMBINATION | Show WHO |
G03FA | Progestogens and estrogens, fixed combinations | Show WHO |
G03FA01 | Norethisterone and estrogen | Show WHO |
G03FA02 | Hydroxyprogesterone and estrogen | Show WHO |
G03FA03 | Ethisterone and estrogen | Show WHO |
G03FA04 | Progesterone and estrogen | Show WHO |
G03FA05 | Methylnortestosterone and estrogen | Show WHO |
G03FA06 | Etynodiol and estrogen | Show WHO |
G03FA07 | Lynestrenol and estrogen | Show WHO |
G03FA08 | Megestrol and estrogen | Show WHO |
G03FA09 | Noretynodrel and estrogen | Show WHO |
G03FA10 | Norgestrel and estrogen | Show WHO |
G03FA11 | Levonorgestrel and estrogen | Show WHO |
G03FA12 | Medroxyprogesterone and estrogen | Show WHO |
G03FA13 | Norgestimate and estrogen | Show WHO |
G03FA14 | Dydrogesterone and estrogen | Show WHO |
G03FA15 | Dienogest and estrogen | Show WHO |
G03FA16 | Trimegestone and estrogen | Show WHO |
G03FA17 | Drospirenone and estrogen | Show WHO |
G03FB | Progestogens and estrogens, sequential preparations | Show WHO |
G03FB01 | Norgestrel and estrogen | Show WHO |
G03FB02 | Lynestrenol and estrogen | Show WHO |
G03FB03 | Chlormadinone and estrogen | Show WHO |
G03FB04 | Megestrol and estrogen | Show WHO |
G03FB05 | Norethisterone and estrogen | Show WHO |
G03FB06 | Medroxyprogesterone and estrogen | Show WHO |
G03FB07 | Medrogestone and estrogen | Show WHO |
G03FB08 | Dydrogesterone and estrogen | Show WHO |
G03FB09 | Levonorgestrel and estrogen | Show WHO |
G03FB10 | Desogestrel and estrogen | Show WHO |
G03FB11 | Trimegestone and estrogen | Show WHO |
G03G | GONADOTROPINS AND OTHER OVULATION STIMULANTS | Show WHO |
G03GA | Gonadotropins | Show WHO |
G03GA01 | Chorionic gonadotrophin | Show WHO |
G03GA02 | Human menopausal gonadotrophin | Show WHO |
G03GA03 | Serum gonadotrophin | Show WHO |
G03GA04 | Urofollitropin | Show WHO |
G03GA05 | Follitropin alfa | Show WHO |
G03GA06 | Follitropin beta | Show WHO |
G03GA07 | Lutropin alfa | Show WHO |
G03GA08 | Choriogonadotropin alfa | Show WHO |
G03GA09 | corifollitropin alfa | Show WHO |
G03GA30 | combinations | Show WHO |
G03GB | Ovulation stimulants, synthetic | Show WHO |
G03GB01 | Cyclofenil | Show WHO |
G03GB02 | Clomifene | Show WHO |
G03GB03 | Epimestrol | Show WHO |
G03H | ANTIANDROGENS | Show WHO |
G03HA | Antiandrogens, plain | Show WHO |
G03HA01 | Cyproterone | Show WHO |
G03HB | Antiandrogens and estrogens | Show WHO |
G03HB01 | Cyproterone and estrogen | Show WHO |
G03X | OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | Show WHO |
G03XA | Antigonadotropins and similar agents | Show WHO |
G03XA01 | Danazol | Show WHO |
G03XA02 | Gestrinone | Show WHO |
G03XB | Antiprogestogens | Show WHO |
G03XB01 | Mifepristone | Show WHO |
G03XC | Selective estrogen receptor modulators | Show WHO |
G03XC01 | Raloxifene | Show WHO |
G04 | UROLOGICALS | Show WHO |
G04B | OTHER UROLOGICALS, INCLUDING ANTISPASMODICS | Show WHO |
G04BA | Acidifiers | Show WHO |
G04BA01 | Ammonium chloride | Show WHO |
G04BA03 | Calcium chloride | Show WHO |
G04BC | Urinary concrement solvents | Show WHO |
G04BD | Urinary antispasmodics | Show WHO |
G04BD01 | Emepronium | Show WHO |
G04BD02 | Flavoxate | Show WHO |
G04BD03 | Meladrazine | Show WHO |
G04BD04 | Oxybutynin | Show WHO |
G04BD05 | Terodiline | Show WHO |
G04BD06 | Propiverine | Show WHO |
G04BD07 | Tolterodine | Show WHO |
G04BD08 | Solifenacin | Show WHO |
G04BD09 | Trospium | Show WHO |
G04BD10 | darifenacin | Show WHO |
G04BD11 | fesoterodine | Show WHO |
G04BE | Drugs used in erectile dysfunction | Show WHO |
G04BE01 | Alprostadil | Show WHO |
G04BE02 | Papaverine | Show WHO |
G04BE03 | Sildenafil | Show WHO |
G04BE04 | Yohimbin | Show WHO |
G04BE05 | Phentolamine | Show WHO |
G04BE06 | Moxisylyte | Show WHO |
G04BE07 | Apomorphine | Show WHO |
G04BE08 | Tadalafil | Show WHO |
G04BE09 | Vardenafil | Show WHO |
G04BE30 | Combinations | Show WHO |
G04BE52 | Papaverine, combinations | Show WHO |
G04BX | Other urologicals | Show WHO |
G04BX01 | Magnesium hydroxide | Show WHO |
G04BX03 | Acetohydroxamic acid | Show WHO |
G04BX06 | Phenazopyridine | Show WHO |
G04BX10 | Succinimide | Show WHO |
G04BX11 | Collagen | Show WHO |
G04BX12 | Phenyl salicylate | Show WHO |
G04BX13 | Dimethyl sulfoxide | Show WHO |
G04BX14 | dapoxetine | Show WHO |
G04C | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY | Show WHO |
G04CA | Alpha-adrenoreceptor antagonists | Show WHO |
G04CA01 | Alfuzosin | Show WHO |
G04CA02 | Tamsulosin | Show WHO |
G04CA03 | Terazosin | Show WHO |
G04CA04 | silodosin | Show WHO |
G04CA51 | alfuzosin and finasteride | Show WHO |
G04CA52 | tamsulosin and dutasteride | Show WHO |
G04CB | Testosterone-5-alpha reductase inhibitors | Show WHO |
G04CB01 | Finasteride | Show WHO |
G04CB02 | Dutasteride | Show WHO |
G04CX | Other drugs used in benign prostatic hypertrophy | Show WHO |
G04CX01 | Pygeum africanum | Show WHO |
G04CX02 | Serenoa repens | Show WHO |
G04CX03 | Mepartricin | Show WHO |
|
|||||||||||||||
|
G |
|
|||||||||||||
|